Finance

Lists
APOLLOHOSP:NSE
Apollo Hospitals Enterprise Ltd
₹8,712.00
-1.19%
(-105.00) 1D
Aug 19, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for APOLLOHOSP...
Open
₹8,817.00
High
₹8,862.50
Low
₹8,695.50
Mkt. cap
1.27T
Avg. vol.
0.00
Volume
298.44K
Dividend
0.23%
Quarterly dividend
₹5.00
Ex-dividend date
Feb 16, 2026
P/E ratio
59.99
52-wk high
₹9,050.00
52-wk low
₹6,696.50
EPS
₹145.21
Shares outstanding
139.13M
No. of employees
44K
Open
₹8,817.00
High
₹8,862.50
Low
₹8,695.50
Mkt. cap
1.27T
Avg. vol.
0.00
Volume
298.44K
Dividend
0.23%
Quarterly dividend
₹5.00
Ex-dividend date
Feb 16, 2026
P/E ratio
59.99
52-wk high
₹9,050.00
52-wk low
₹6,696.50
EPS
₹145.21
Shares outstanding
139.13M
No. of employees
44K
News stories
From web sources and news partners
Profile
Apollo Hospitals Enterprise Limited is an Indian multinational healthcare group headquartered in Chennai. It is the second largest for-profit private hospital network in India after Manipal Hospitals, with a network of 71 owned and managed hospitals. Along with the eponymous hospital chain, the company also operates pharmacies, primary care and diagnostic centres, telehealth clinics, and digital healthcare services among others through its subsidiaries. The company was founded by Prathap C. Reddy in 1983 as the first corporate healthcare provider in India. Several of Apollo's hospitals have been among the first in India to receive international healthcare accreditation by the America-based Joint Commission International as well as NABH accreditation. Apollo Hospitals and its subsidiaries like Apollo Dental is infamous for overcharging, forceful transplants, corruption and cronyism. Wikipedia
About Apollo Hospitals Enterprise Ltd
CEO-
Employees44K
FoundedSep 18, 1983
Headquarters-
SectorHealth care provider
Websiteapollohospitals.com
Last report
Aug 13, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹40.37 / ₹39.58
+1.99%beat
Revenue / Est. (INR)
70.44B / 68.91B
+2.21%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
63.04B
64.77B
66.06B
70.44B
Cost of goods sold
40.10B
41.31B
45.90B
43.93B
Cost of revenue
40.10B
41.31B
45.90B
43.93B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
6.12B
-
Operating expense
15.70B
16.00B
12.18B
17.94B
Total operating expenses
55.80B
57.31B
58.09B
61.86B
Operating income
7.23B
7.46B
7.97B
8.57B
Other non operating income
547.00M
528.00M
-2.14B
488.00M
EBT including unusual items
6.75B
6.82B
7.22B
7.99B
EBT excluding unusual items
6.75B
7.01B
6.43B
7.99B
Income tax expense
1.81B
1.66B
1.70B
1.88B
Effective tax rate
26.78%
24.30%
23.58%
23.59%
Other operating expenses
13.52B
13.81B
3.82B
15.58B
Net income
4.77B
5.02B
5.29B
5.81B
Net profit margin
7.57%
7.75%
8.01%
8.24%
Earnings per share
33.19
35.95
36.76
40.37
Interest and investment income
-
-
767.00M
-
Interest expense
-1.10B
-1.13B
-256.00M
-1.20B
Net interest expenses
-1.10B
-1.13B
511.00M
-1.20B
Depreciation and amortization charges
2.18B
2.19B
2.24B
2.35B
EBITDA
9.40B
8.77B
9.37B
9.97B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps